Of cells and microparticles: Assets and liabilities of HLA antibody detection

Robert S. Liwski, Howard M. Gebel

Research output: Contribution to journalReview articlepeer-review

29 Citations (Scopus)

Abstract

The evolution of antibody detection from cell-to bead-based technology has positively impacted the ability to allocate organs in a safe and timely manner. The devil, of course, is in the details that delineate how these assays are performed and applied and to recognize that while there have been some truly amazing technological advances (assets), they are still imperfect and subject to error (liabilities). This review identifies the strengths of HLA antibody assays, highlights their weaknesses and offers approaches for standardization.

Original languageEnglish
Pages (from-to)S1-S6
JournalTransplantation
Volume102
Issue number1S
DOIs
Publication statusPublished - Jan 1 2018

Bibliographical note

Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc. All rights reserved.

ASJC Scopus Subject Areas

  • Transplantation

Fingerprint

Dive into the research topics of 'Of cells and microparticles: Assets and liabilities of HLA antibody detection'. Together they form a unique fingerprint.

Cite this